Stefan Leucht1, Hein Fennema2, Rolf R Engel3, Marion Kaspers-Janssen4, Armin Szegedi5. 1. Department of Psychiatry and Psychotherapy, Technische Universität München, Klinikum rechts der Isar, Ismaningerstr. 22, 81675 München, Germany. Electronic address: Stefan.Leucht@tum.de. 2. Janssen Pharmaceutical, Belgium. 3. Department of Psychiatry and Psychotherapy, Ludwig-Maximilians Universität München, Germany. 4. OCS Consulting, The Netherlands. 5. Allergan, USA.
Abstract
BACKGROUND: The Hamilton Depression Rating Scale (HAM-D) and the Montgomery Asberg Depression Rating Scale (MADRS) are scales used frequently to rate the symptoms of depression. There are many situations in which it is important to know what a given total score or a percent reduction from baseline score of one scale means in relation to the other scale. METHOD: We used the equipercentile linking method to identify corresponding scores of simultaneous HAM-D and MADRS ratings in 4388 patients from 31 mirtazapine trials in major depressive disorder. Data were collected at baseline and at weeks 1, 2 and 4. RESULTS: HAM-D scores of 10, 20, 30 and 40 roughly corresponded to MADRS scores of 13, 26, 39 and 52-53, respectively. An absolute HAM-D improvement of 10, 20, 25 points corresponded to a MADRS improvement of 12, 26, and 34. A percentage improvement from baseline of the HAM-D was approximately the same as a percentage improvement on the MADRS. CONCLUSION: These results are important for the comparison of trials that used the HAM-D and MADRS. We present conversion tables for future research.
BACKGROUND: The Hamilton Depression Rating Scale (HAM-D) and the Montgomery Asberg Depression Rating Scale (MADRS) are scales used frequently to rate the symptoms of depression. There are many situations in which it is important to know what a given total score or a percent reduction from baseline score of one scale means in relation to the other scale. METHOD: We used the equipercentile linking method to identify corresponding scores of simultaneous HAM-D and MADRS ratings in 4388 patients from 31 mirtazapine trials in major depressive disorder. Data were collected at baseline and at weeks 1, 2 and 4. RESULTS: HAM-D scores of 10, 20, 30 and 40 roughly corresponded to MADRS scores of 13, 26, 39 and 52-53, respectively. An absolute HAM-D improvement of 10, 20, 25 points corresponded to a MADRS improvement of 12, 26, and 34. A percentage improvement from baseline of the HAM-D was approximately the same as a percentage improvement on the MADRS. CONCLUSION: These results are important for the comparison of trials that used the HAM-D and MADRS. We present conversion tables for future research.
Authors: Lisa T Eyler; Michelle E Aebi; Rebecca E Daly; Kristen Hansen; Curtis Tatsuoka; Robert C Young; Martha Sajatovic Journal: Am J Geriatr Psychiatry Date: 2019-04-18 Impact factor: 4.105
Authors: Rebecca B Price; Nicholas Kissel; Andrew Baumeister; Rebecca Rohac; Mary L Woody; Elizabeth D Ballard; Carlos A Zarate; William Deakin; Chadi G Abdallah; Adriana Feder; Dennis S Charney; Michael F Grunebaum; J John Mann; Sanjay J Mathew; Bronagh Gallagher; Declan M McLoughlin; James W Murrough; Suresh Muthukumaraswamy; Rebecca McMillan; Rachael Sumner; George Papakostas; Maurizio Fava; Rebecca Hock; Jennifer L Phillips; Pierre Blier; Paulo Shiroma; Peter Šóš; Tung-Ping Su; Mu-Hong Chen; Mikael Tiger; Johan Lundberg; Samuel T Wilkinson; Meredith L Wallace Journal: Mol Psychiatry Date: 2022-09-07 Impact factor: 13.437
Authors: Toshi A Furukawa; Mirjam Reijnders; Sanae Kishimoto; Masatsugu Sakata; Robert J DeRubeis; Sona Dimidjian; David J A Dozois; Ulrich Hegerl; Steven D Hollon; Robin B Jarrett; François Lespérance; Zindel V Segal; David C Mohr; Anne D Simons; Lena C Quilty; Charles F Reynolds; Claudio Gentili; Stefan Leucht; Rolf R Engel; Pim Cuijpers Journal: Epidemiol Psychiatr Sci Date: 2019-03-14 Impact factor: 6.892
Authors: Erik E Rabin; Miri Kim; Andreas Mozny; Krislyn Cardoza; April C Bell; Lijie Zhai; Prashant Bommi; Kristen L Lauing; Amanda L King; Terri S Armstrong; Theresa L Walunas; Deyu Fang; Ishan Roy; John D Peipert; Erica Sieg; Xinlei Mi; Christina Amidei; Rimas V Lukas; Derek A Wainwright Journal: Brain Behav Immun Health Date: 2022-03-23